Kiniksa Pharmaceuticals

Home » Kiniksa Pharmaceuticals

IPO

Kiniksa Pharmaceuticals

We are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.

Symbol

KNSA

Price Range
$17.00 - $19.00

Final Shares
7,000,000

Anticipated Date
TBD

Underwriters
Goldman Sachs & Co. LLC, J.P. Morgan, JMP Securities, Wedbush PacGrow

To view the prospectus for Kiniksa Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253